• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活剂需要一种共受体来增强N-甲基-D-天冬氨酸受体功能。

Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.

作者信息

Samson Andre L, Nevin Simon T, Croucher David, Niego Be'eri, Daniel Philip B, Weiss Thomas W, Moreno Eliza, Monard Denis, Lawrence Daniel A, Medcalf Robert L

机构信息

Australian Centre for Blood Diseases, Monash University, AMREP, Melbourne, Victoria, Australia.

出版信息

J Neurochem. 2008 Nov;107(4):1091-101. doi: 10.1111/j.1471-4159.2008.05687.x. Epub 2008 Sep 15.

DOI:10.1111/j.1471-4159.2008.05687.x
PMID:18796005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3198853/
Abstract

Glutamate is the main excitatory neurotransmitter of the CNS. Tissue-type plasminogen activator (tPA) is recognized as a modulator of glutamatergic neurotransmission. This attribute is exemplified by its ability to potentiate calcium signaling following activation of the glutamate-binding NMDA receptor (NMDAR). It has been hypothesized that tPA can directly cleave the NR1 subunit of the NMDAR and thereby potentiate NMDA-induced calcium influx. In contrast, here we show that this increase in NMDAR signaling requires tPA to be proteolytically active, but does not involve cleavage of the NR1 subunit or plasminogen. Rather, we demonstrate that enhancement of NMDAR function by tPA is mediated by a member of the low-density lipoprotein receptor (LDLR) family. Hence, this study proposes a novel functional relationship between tPA, the NMDAR, a LDLR and an unknown substrate which we suspect to be a serpin. Interestingly, whilst tPA alone failed to cleave NR1, cell-surface NMDARs did serve as an efficient and discrete proteolytic target for plasmin. Hence, plasmin and tPA can affect the NMDAR via distinct avenues. Altogether, we find that plasmin directly proteolyses the NMDAR whilst tPA functions as an indirect modulator of NMDA-induced events via LDLR engagement.

摘要

谷氨酸是中枢神经系统主要的兴奋性神经递质。组织型纤溶酶原激活剂(tPA)被认为是谷氨酸能神经传递的调节剂。这一特性体现在其能够在谷氨酸结合的N-甲基-D-天冬氨酸受体(NMDAR)激活后增强钙信号传导。有人推测,tPA可以直接切割NMDAR的NR1亚基,从而增强NMDA诱导的钙内流。相比之下,我们在此表明,NMDAR信号的这种增加需要tPA具有蛋白水解活性,但不涉及NR1亚基或纤溶酶原的切割。相反,我们证明tPA对NMDAR功能的增强是由低密度脂蛋白受体(LDLR)家族的一个成员介导的。因此,本研究提出了tPA、NMDAR、LDLR和一种未知底物(我们怀疑是一种丝氨酸蛋白酶抑制剂)之间的一种新的功能关系。有趣的是,虽然单独的tPA未能切割NR1,但细胞表面的NMDAR确实是纤溶酶的一个有效且离散的蛋白水解靶点。因此,纤溶酶和tPA可以通过不同途径影响NMDAR。总之,我们发现纤溶酶直接对NMDAR进行蛋白水解,而tPA通过与LDLR结合作为NMDA诱导事件的间接调节剂。

相似文献

1
Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.组织型纤溶酶原激活剂需要一种共受体来增强N-甲基-D-天冬氨酸受体功能。
J Neurochem. 2008 Nov;107(4):1091-101. doi: 10.1111/j.1471-4159.2008.05687.x. Epub 2008 Sep 15.
2
Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors.组织型纤溶酶原激活剂通过提高突触外NMDA受体的表面动力学来控制神经元死亡。
Cell Death Dis. 2016 Nov 10;7(11):e2466. doi: 10.1038/cddis.2016.279.
3
Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits.含有NMDA受体亚基NR3家族的兴奋性甘氨酸受体。
Nature. 2002 Feb 14;415(6873):793-8. doi: 10.1038/nature715. Epub 2002 Jan 30.
4
The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors.丝氨酸蛋白酶纤溶酶切割NR2A亚基的氨基末端结构域,以解除锌对N-甲基-D-天冬氨酸受体的抑制作用。
J Biol Chem. 2009 May 8;284(19):12862-73. doi: 10.1074/jbc.M805123200. Epub 2009 Feb 24.
5
Cleavage of the NR2B subunit amino terminus of N-methyl-D-aspartate (NMDA) receptor by tissue plasminogen activator: identification of the cleavage site and characterization of ifenprodil and glycine affinities on truncated NMDA receptor.组织型纤溶酶原激活物对 N-甲基-D-天冬氨酸(NMDA)受体 NR2B 亚基氨基末端的切割:切割位点的鉴定以及对截断型 NMDA 受体上异氟烷和甘氨酸亲和力的特性分析。
J Biol Chem. 2012 Jul 20;287(30):25520-9. doi: 10.1074/jbc.M112.374397. Epub 2012 May 18.
6
Role of the NR2A/2B subunits of the N-methyl-D-aspartate receptor in glutamate-induced glutamic acid decarboxylase alteration in cortical GABAergic neurons in vitro.NR2A/2B 亚基型 N-甲基-D-天冬氨酸受体在体外谷氨酸诱导皮质 GABA 能神经元谷氨酸脱羧酶改变中的作用。
Neuroscience. 2010 Dec 29;171(4):1075-90. doi: 10.1016/j.neuroscience.2010.09.050. Epub 2010 Oct 20.
7
The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits.内源性激动剂喹啉酸和非内源性高喹啉酸可区分NMDAR2受体亚基。
Neurochem Int. 1996 Apr;28(4):445-52. doi: 10.1016/0197-0186(95)00091-7.
8
Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury.组织型纤溶酶原激活剂可保护海马神经元免受氧糖剥夺损伤。
J Neurosci Res. 2001 Mar 1;63(5):388-94. doi: 10.1002/1097-4547(20010301)63:5<388::AID-JNR1033>3.0.CO;2-T.
9
Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.鉴定和表征新型 NMDA 受体拮抗剂,对 NR2A- 受体亚型选择性高于 NR2B- 受体亚型。
J Pharmacol Exp Ther. 2010 Dec;335(3):636-44. doi: 10.1124/jpet.110.172544. Epub 2010 Sep 1.
10
The DREAM protein negatively regulates the NMDA receptor through interaction with the NR1 subunit.DREAM 蛋白通过与 NR1 亚基相互作用负调控 NMDA 受体。
J Neurosci. 2010 Jun 2;30(22):7575-86. doi: 10.1523/JNEUROSCI.1312-10.2010.

引用本文的文献

1
Modeling and correction of protein conformational disease in iPSC-derived neurons through personalized base editing.通过个性化碱基编辑对诱导多能干细胞衍生神经元中的蛋白质构象疾病进行建模和校正。
Mol Ther Nucleic Acids. 2024 Dec 21;36(1):102441. doi: 10.1016/j.omtn.2024.102441. eCollection 2025 Mar 11.
2
Intracellular tPA-PAI-1 interaction determines VLDL assembly in hepatocytes.细胞内 tPA-PAI-1 相互作用决定肝细胞中 VLDL 的组装。
Science. 2023 Sep;381(6661):eadh5207. doi: 10.1126/science.adh5207. Epub 2023 Sep 1.
3
Low-density lipoprotein receptor-related protein-1 (LRP1) in the glial lineage modulates neuronal excitability.

本文引用的文献

1
Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.组织型纤溶酶原激活剂激活血小板衍生生长因子CC会损害缺血性中风期间的血脑屏障完整性。
Nat Med. 2008 Jul;14(7):731-7. doi: 10.1038/nm1787. Epub 2008 Jun 22.
2
The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors.低密度脂蛋白受体相关蛋白1β链的第二个NPXY基序在组织型纤溶酶原激活物介导的N-甲基-D-天冬氨酸受体激活中的功能作用
J Biol Chem. 2008 May 2;283(18):12004-13. doi: 10.1074/jbc.M707607200. Epub 2008 Mar 5.
3
Key role of tissue plasminogen activator in neurovascular coupling.
神经胶质谱系中的低密度脂蛋白受体相关蛋白1(LRP1)调节神经元兴奋性。
Front Netw Physiol. 2023 Jun 13;3:1190240. doi: 10.3389/fnetp.2023.1190240. eCollection 2023.
4
An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages.一种靶向细胞表面葡萄糖调节蛋白-78 的抗体可抑制巨噬细胞中炎症细胞因子和纤溶酶原激活物抑制剂的表达。
J Cell Biochem. 2023 May;124(5):743-752. doi: 10.1002/jcb.30401. Epub 2023 Mar 22.
5
Blood tissue Plasminogen Activator (tPA) of liver origin contributes to neurovascular coupling involving brain endothelial N-Methyl-D-Aspartate (NMDA) receptors.肝脏来源的血组织纤溶酶原激活物(tPA)有助于涉及脑内皮 N-甲基-D-天冬氨酸(NMDA)受体的神经血管偶联。
Fluids Barriers CNS. 2023 Feb 3;20(1):11. doi: 10.1186/s12987-023-00411-w.
6
Tissue-type plasminogen activator induces conditioned receptive field plasticity in the mouse auditory cortex.组织型纤溶酶原激活剂诱导小鼠听觉皮层的条件感受野可塑性。
iScience. 2023 Jan 7;26(2):105947. doi: 10.1016/j.isci.2023.105947. eCollection 2023 Feb 17.
7
Modulations of the neuronal trafficking of tissue-type plasminogen activator (tPA) influences glutamate release.神经元组织型纤溶酶原激活物(tPA)转运的调节影响谷氨酸释放。
Cell Death Dis. 2023 Jan 18;14(1):34. doi: 10.1038/s41419-022-05543-9.
8
Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases.靶向神经血管单元的 NMDA 受体:中枢神经系统疾病的过去和未来治疗方法。
Int J Mol Sci. 2022 Sep 7;23(18):10336. doi: 10.3390/ijms231810336.
9
Platelet-targeted thrombolysis for treatment of acute ischemic stroke.血小板靶向溶栓治疗急性缺血性脑卒中。
Blood Adv. 2023 Feb 28;7(4):561-574. doi: 10.1182/bloodadvances.2021006691.
10
tPA-NMDAR Signaling Blockade Reduces the Incidence of Intracerebral Aneurysms.tPA-NMDAR 信号阻断可降低颅内动脉瘤的发生率。
Transl Stroke Res. 2022 Dec;13(6):1005-1016. doi: 10.1007/s12975-022-01004-9. Epub 2022 Mar 21.
组织型纤溶酶原激活剂在神经血管耦合中的关键作用。
Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1073-8. doi: 10.1073/pnas.0708823105. Epub 2008 Jan 14.
4
Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system.组织纤溶酶原激活物系统对海马体中NR2B调节的情境性恐惧的调节作用。
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13473-8. doi: 10.1073/pnas.0705848104. Epub 2007 Aug 2.
5
Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.组织型纤溶酶原激活剂对交感神经活动的调节独立于纤溶酶原和尿激酶。
J Pharmacol Exp Ther. 2007 Jul;322(1):265-73. doi: 10.1124/jpet.107.121335. Epub 2007 Apr 11.
6
Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.抗NR1 N端结构域疫苗接种揭示了组织型纤溶酶原激活剂对NMDA受体介导的毒性和空间记忆的关键作用。
J Cell Sci. 2007 Feb 15;120(Pt 4):578-85. doi: 10.1242/jcs.03354. Epub 2007 Jan 23.
7
Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit.组织型纤溶酶原激活物介导的星形胶质细胞低密度脂蛋白受体相关蛋白脱落增加了神经血管单元的通透性。
Blood. 2007 Apr 15;109(8):3270-8. doi: 10.1182/blood-2006-08-043125. Epub 2006 Dec 14.
8
Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo.抑瘤素M是一种神经保护细胞因子,在体外和体内均能抑制兴奋性毒性损伤。
FASEB J. 2006 Nov;20(13):2369-71. doi: 10.1096/fj.06-5850fje. Epub 2006 Oct 5.
9
The plasminogen activator system modulates sympathetic nerve function.纤溶酶原激活物系统调节交感神经功能。
J Exp Med. 2006 Sep 4;203(9):2191-200. doi: 10.1084/jem.20060077. Epub 2006 Aug 28.
10
The synthesis, structural characterization, and receptor specificity of the alpha-conotoxin Vc1.1.α-芋螺毒素Vc1.1的合成、结构表征及受体特异性
J Biol Chem. 2006 Aug 11;281(32):23254-63. doi: 10.1074/jbc.M604550200. Epub 2006 Jun 5.